Effect of Algomed, Menta longifolia, Chamomile, Althaea rosea, Malva sylvestris supplements on the Severity and Consequences of Coronavirus 19 disease (COVID-19)

Effect of Algomed, Menta longifolia, Chamomile, Althaea rosea, Malva sylvestris supplements on the Severity and Consequences of COVID-19

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20151228025732N51

Enrollment

Registered

2020-04-08

Start date

2020-03-18

Completion date

Unknown

Last updated

2020-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronavirus. Coronavirus infection, unspecified

Interventions

Intervention 1: Intervention group: In addition to the treatment protocol, patients are given four daily doses of 300 mg of Vulgaris.C supplemented with Herbal tea (2g Pennyroyal

2g chamomile, 1.4g Hollyhocks and 0.6g Mallow). Intervention 2: Control group: Treatment is according to the protocol and is for comparison only with the intervention group.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: COVID-19 Patients Admitted to Kowsar Hospital Respiratory Ward

Exclusion criteria

Exclusion criteria: Malignant diseases (Cancers) Severe renal, liver and heart failure Taking anticoagulants especially warfarin Pregnancy Lactating mothers

Design outcomes

Primary

Measure	Time frame
Clinical symptoms (Coronavirus infection). Timepoint: Before starting the study and daily until discharge. Method of measurement: Laboratory values and radiographic changes or CT scans.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRahimeh Eskandarian

Semnan University of Medical Sciences

are20935@gmail.com+98 23 3345 1336

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 15, 2026